Larvol Delta - BBT003-A-NOVEL-IL23P19-X-TL1A-BISPECIFIC-ANTIBODY-WITH-EXTENDED-HALFLIFE-DEMONSTRATES-A-POTENTIAL-BESTINDISEASE-PROFILE-IN-PRECLINICAL-MODELS-OF-INFLAMMATORY-BOWEL-DISEASE

BBT003 - Bambusa Therapeutics

https://programme.ueg.eu/2026/week/details/sessions/383

Thang Ho

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next